Skip to main content
. 2021 Dec 23;19:81. doi: 10.1186/s12962-021-00334-z

Table 5.

Scenario analysis

Strategy Cost (USD) QALYs ΔC ΔQALYs BNP vs. Standard clinical assessment
Scenario 1: EQ-5D values from Emrani study
 BNP 1835 1.9 − 541 0.12 Dominant
 Standard clinical assessment 2376 1.78
Scenario 2: time horizon 10 years
 BNP 1805 2.15 − 551 0.15 Dominant
 Standard clinical assessment 2356 2
Scenario 2: time horizon 20 years
 BNP 1832 2.18 542 0.11 Dominant
 Standard clinical assessment 2374 2.07